Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Savage

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Diabetes|September 28, 2001
Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humansD B Savage, C P Sewter, E S Klenk, et al.
European Journal of Clinical Nutrition|November 28, 2013
An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic diseaseL P E Watson, P Raymond-Barker, C Moran, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 13, 2016
Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutationsT Demir, H Onay, D B Savage, et al.
Diabetologia|September 17, 2009
Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individualsF M Finucane, J Luan, N J Wareham, et al.
International Journal of Obesity (2005)|October 22, 2009
Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descentS Romeo, F Sentinelli, S Dash, et al.
Diabetologia|August 10, 2004
Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA geneD B Savage, M A Soos, A Powlson, et al.
Science (New York, N.Y.)|October 8, 2011
An activating mutation of AKT2 and human hypoglycemiaK Hussain, B Challis, N Rocha, et al.
Diabetologia|April 21, 2009
IRS2 variants and syndromes of severe insulin resistanceW E Bottomley, M A Soos, C Adams, et al.
Diabetes|August 13, 2014
Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophyK Kozusko, Vhm Tsang, W Bottomley, et al.
Diabetologia|January 7, 2010
The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trialF M Finucane, S J Sharp, L R Purslow, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Diabetes|September 28, 2001
Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humansD B Savage, C P Sewter, E S Klenk, et al.
European Journal of Clinical Nutrition|November 28, 2013
An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic diseaseL P E Watson, P Raymond-Barker, C Moran, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 13, 2016
Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutationsT Demir, H Onay, D B Savage, et al.
Diabetologia|September 17, 2009
Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individualsF M Finucane, J Luan, N J Wareham, et al.
International Journal of Obesity (2005)|October 22, 2009
Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descentS Romeo, F Sentinelli, S Dash, et al.
Diabetologia|August 10, 2004
Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA geneD B Savage, M A Soos, A Powlson, et al.
Science (New York, N.Y.)|October 8, 2011
An activating mutation of AKT2 and human hypoglycemiaK Hussain, B Challis, N Rocha, et al.
Diabetologia|April 21, 2009
IRS2 variants and syndromes of severe insulin resistanceW E Bottomley, M A Soos, C Adams, et al.
Diabetes|August 13, 2014
Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophyK Kozusko, Vhm Tsang, W Bottomley, et al.
Diabetologia|January 7, 2010
The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trialF M Finucane, S J Sharp, L R Purslow, et al.
Pageof 3